The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis.
about
Clinical efficacy of blue light full body irradiation as treatment option for severe atopic dermatitisAtopic dermatitis: natural history, diagnosis, and treatmentOral H1 antihistamines as ‘add-on’ therapy to topical treatment for eczemaEmollients and moisturisers for eczemaTopical tacrolimus for atopic dermatitisDifferent strategies for using topical corticosteroids for established eczemaEmollients for eczemaA Review of Multidisciplinary Interventions in Atopic DermatitisImmune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted TherapeuticsHealth outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010.Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trialContagious itch in humans: a study of visual 'transmission' of itch in atopic dermatitis and healthy subjects.A pilot study showing pulsed-dye laser treatment improves localized areas of chronic atopic dermatitis.The Urban Environment and Childhood Asthma (URECA) birth cohort study: design, methods, and study population.Topical application of Jaungo in atopic dermatitis patients: study protocol for a randomized, controlled trial.Circulating TSLP associates with decreased wheezing in non-atopic preschool children: data from the URECA birth cohortHigh prevalence of skin diseases and need for treatment in a middle-aged population. A Northern Finland Birth Cohort 1966 studyCowhage-induced itch as an experimental model for pruritus. A comparative study with histamine-induced itch.The Traditional Chinese Medicine and Relevant Treatment for the Efficacy and Safety of Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Translation and validation of Portuguese of a questionnaire for evaluation of psychosomatic symptoms in adults with atopic dermatitisLongitudinal relationship of early life immunomodulatory T cell phenotype and function to development of allergic sensitization in an urban cohortEfficacy and safety of sodium hypochlorite (bleach) baths in patients with moderate to severe atopic dermatitis in Malaysia.Influence of pimecrolimus cream 1% on different morphological signs of eczema in infants with atopic dermatitis.Local rhamnosoft, ceramides and L-isoleucine in atopic eczema: a randomized, placebo controlled trialAtopic dermo-respiratory syndrome is a correlate of eczema herpeticum.Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME).Pimecrolimus cream 1% in the management of atopic dermatitis in pediatric patients: a meta-analysisMorus alba L. suppresses the development of atopic dermatitis induced by the house dust mite in NC/Nga mice.A pilot comparison study of four clinician-rated atopic dermatitis severity scales.Role of mild cleansing in the management of patient skin.Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis.Dietary treatment of childhood atopic eczema/dermatitis syndrome (AEDS).Consensus guidelines in diagnosis and treatment of atopic dermatitis.Treatment outcomes of secondarily impetiginized pediatric atopic dermatitis lesions and the role of oral antibiotics.High prevalence of methicillin resistance and PVL genes among Staphylococcus aureus isolates from the nares and skin lesions of pediatric patients with atopic dermatitis.The role of topical calcineurin inhibitors in atopic dermatitis.A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients.Effect of Alpinia katsumadai Hayata on House Dust Mite-Induced Atopic Dermatitis in NC/Nga MiceProblem-based learning: a review of current issues relevant to physiotherapy education.Increased plasma concentration of vascular endothelial growth factor in patients with atopic dermatitis and its relation to disease severity and platelet activation.
P2860
Q21004108-1BAD7F5A-7007-4987-853C-FBCCEE8F8699Q21284712-21E61FC1-DAF6-44C1-8712-EE8CF136A578Q24185954-516A4148-6282-471D-AEBA-173BAFEF6BBAQ24186075-7BE13AE1-7A42-493D-9A71-C09E89363361Q24186624-23B8B1C4-C575-4052-98CA-A54CE5FDE691Q24199012-454F536C-5E81-4344-A91D-AD1FFC21483BQ24239853-E0EBFC42-51E8-4874-802B-D00A3CB13C2EQ26799480-F75450A4-070C-47A6-A980-A19E090671E4Q26799532-03FD66F5-C035-4557-B8D1-066428DA284EQ27691377-4D823BFA-9BDD-440F-8122-7DA3F19CF57AQ28263006-2A84678C-52BD-4B76-99C4-CBFCB5AEE022Q30500946-591BCA5B-5402-4DE6-BDA0-D72022E43FFCQ33315158-F74AD7F9-F484-4C3A-9963-B502165E569EQ33441873-4394E154-92EA-4F36-A27E-986F0CBBDA46Q33556464-D4F16339-81D4-4005-875E-AC96A599DEE1Q33681021-31C55EE4-38CC-4724-A300-49663419E41FQ33728094-3E0EFE77-138D-41DD-A7C9-BF04B79DC365Q33851774-A2AB0E78-3F0B-40F3-A6EB-FB8A424363D4Q33872732-77935F7A-3280-43B4-8353-398D8420FD67Q34140507-DECA9600-8C4B-4052-93F8-2952B3B93DCAQ34171237-914EBDFE-06BD-488B-A435-73058B4458A7Q34376656-4887BFF9-EAC6-4ED3-95AE-8FD6311023CDQ34552586-EE5B6596-75D7-4901-8763-B7FAD09A49D8Q34658901-9BDB69A0-CBC6-4486-ACB6-9AF36534D300Q34860988-E7514EF6-F644-46C8-87E5-9AC41A917582Q34982055-B1B89B91-A6E0-407A-BEBA-3CC8157B2DCFQ35137660-63DD85BE-E3DE-49E7-8046-4E855D8E464FQ35154709-A7BC3673-C7C5-49D3-AA48-F8A42D74B9BAQ35609349-20F9B543-9B31-47C4-AC09-4F8FF4C81C16Q35631634-21515B24-79C8-4790-8B2D-278F1AE77B45Q35809490-37F9251D-06B3-43EF-B606-83F2CAA33B43Q35831650-DF64EC5C-6DD8-4A79-8FF9-47B4BCA5D200Q35831654-2F66EB4C-0623-4581-9CA9-329111E20891Q35846347-D5E7D9FC-EAF4-4B33-9F23-9F932BE007F3Q35881330-010D88BD-0EF7-48E7-ACB6-7631660F9E43Q35952647-4BFE7A9E-16BC-4FF6-B749-1AD9DA33D847Q36232707-EC9AEB0D-9E20-4BE7-A8CB-10C3FDC0440DQ36307651-187C2C8E-5621-4A48-98A5-64743693A829Q36356956-EB6CD681-E3AE-4818-8AFD-386F7EAEED98Q36394290-422D1FD7-7607-44B1-8D52-39E2472552B9
P2860
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
The eczema area and severity i ...... iability in atopic dermatitis.
@en
The eczema area and severity index
@nl
type
label
The eczema area and severity i ...... iability in atopic dermatitis.
@en
The eczema area and severity index
@nl
prefLabel
The eczema area and severity i ...... iability in atopic dermatitis.
@en
The eczema area and severity index
@nl
P2093
P2860
P1476
The eczema area and severity i ...... iability in atopic dermatitis.
@en
P2093
J M Hanifin
M Thurston
The Easi Evaluator Group
P2860
P356
10.1034/J.1600-0625.2001.100102.X
P577
2001-02-01T00:00:00Z